Chemoinformaics analysis of 3,4-DI-O-CAFFEOYLQUINIC-ACID
Molecular Weight | 660.581 | nRot | 12 |
Heavy Atom Molecular Weight | 628.325 | nRig | 25 |
Exact Molecular Weight | 660.169 | nRing | 3 |
Solubility: LogS | -2.445 | nHRing | 0 |
Solubility: LogP | 1.418 | No. of Aliphatic Rings | 1 |
Acid Count | 2 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 2 |
nHetero | 16 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 31 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 16 | No. of Arom Bond | 12 |
nHA | 14 | APOL | 85.9394 |
nHD | 8 | BPOL | 41.6506 |
QED | 0.069 |
Synth | 4.63 |
Natural Product Likeliness | 1.486 |
NR-PPAR-gamma | 0.84 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.741 |
HIA | 0.98 |
CACO-2 | -6.363 |
MDCK | 0.0000174 |
BBB | 0.024 |
PPB | 0.968435 |
VDSS | 0.42 |
FU | 0.0389002 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.02 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.035 |
CYP2c9-inh | 0.293 |
CYP2c9-sub | 0.593 |
CYP2d6-inh | 0.027 |
CYP2d6-sub | 0.124 |
CYP3a4-inh | 0.081 |
CYP3a4-sub | 0.025 |
CL | 4.612 |
T12 | 0.97 |
hERG | 0.013 |
Ames | 0.01 |
ROA | 0.039 |
SkinSen | 0.184 |
Carcinogencity | 0.085 |
EI | 0.018 |
Respiratory | 0.011 |
NR-Aromatase | 0.225 |
Antiviral | Yes |
Prediction | 0.771112 |